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Objective: The purpose of this study is to measure health care utilization in Australian
cancer patients based on their demographic, geographic and socioeconomic backgrounds.
Method: A total of 13,609 participants (aged 15 and over) from 7,230 households were
interviewed as part of Wave 13 of the national Household, Income and Labour Dynamics in
Australia (HILDA) survey. Five hundred and seventeen participants indicated a current cancer
diagnosis with 90% of those receiving active treatment at the time of interview. Independent
sample t-tests, Pearson Chi-sq tests, Kruskal‒Wallis H test, binary logistic regression and a
zero-inflated Poisson regression were used to examine inequality in health care use.
Results: Demographic and sociocultural factors such as advancing age, gender, low income,
low education status, rurality, no private health insurance, increased psychological distress
and less access to specialist care are associated with lower health care utilization among
cancer patients. However, models of care such as general practitioner-led cancer care is
preferable in younger individuals with cancer, while accessing specialist care is associated
with lower rates of hospitalization and higher levels of psychological distress increases
hospital length of stay.
Conclusions: The findings of lower health care utilization by those cancer patients with
characteristics of disadvantage have implications for policy development and intervention
design. Broadly, policies targeting structural social inequities are likely to increase health
care utilization among the most affected/disadvantaged populations. Further investigation is
needed to identify potential links between health care utilization and cancer outcomes as a
step toward targeted interventions for improving outcomes in the adversely affected groups.
Keywords: cancer, health care utilization, primary preventive care, inequality, psychological
distress, HILDA
Introduction
In 2018, there were approximately 18.1 million new diagnoses of cancer and the
disease was responsible for an estimated 9.6 million deaths globally.1 For Australia,
the incidence of new cancer cases has more than doubled since 1982 with an
estimated 50,000 cancer-related deaths in 2017.2 Although overall cancer survival
rates have improved by 20% from 1984 to 2013 in Australia, 13% of premature
cancer deaths were related to socioeconomic disparities between 2004 and 2008.3,4
Cancer is now a leading cause of illness and death in Australia, with 1 in 3
Australians dying from the disease.3
With the incidence of cancer increasing, so too is cancer-related health care
utilization which is defined as “an individual’s use of health care to prevent and/or
cure health conditions, promote and sustain good health, and get professional
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information about one’s health status and/or prognosis”.5
Health care utilization among cancer patients in Australia
is extensive with approximately 10% of all hospitaliza-
tions being cancer-related with an average length of stay of
7.8 days in 2014–2015.3 Cancer-related hospital bed days
have also increased between 70% and 80% over the period
from 1998 to 2011.6 For palliative cancer care, health care
utilization and costs also factor with increased presenta-
tions to emergency, admission to hospital and intensive
care admission in the last 30 days of life.7 Moreover, the
cost of health care utilization often extends beyond direct
costs to the system and onto individuals, even despite
Australia’s universal health care coverage. Financial dis-
tress is increasingly a factor for individuals living with
cancer in Australia with moderate to extreme financial
burden caused by out-of-pocket expenditure reported in
over one-third (34%) of patients in a 2016 study.8 This
issue has gained considerable political attention in the
2019 Australian Federal election campaign with the oppo-
sition promising a $A2.4 billion package to address exces-
sive out-of-pocket expenses for those with cancer.
In this context, the economic impact of cancer is
considerable9 with the cost of cancer care estimated to increase
significantly to $7.8 billion by 2022–2023 in Australia.10
Despite funding allocations growing alongside the demand
for health care, resourcing cancer care is complex as cancer
incidence and outcomes can vary based on socioeconomic
factors such as age, place of residence and income status.3,11,12
Worldwide, health care utilization in cancer patients has been
predicted by demographic factors such as rurality,4,6,13 cancer
type14–16 and socioeconomic status.17,18 However, the burden
of cancer often falls most heavily on disadvantaged popula-
tions with a 2016 study concluding that 13% of premature
cancer deaths were related to socioeconomic disparities in the
period from 2004 to 2008.4
Resourcing health care utilization in the context of sub-
stantial variations in health care utilization and cancer out-
comes are therefore dependent on identifying and responding
to a range of cancer-related demographic and socioeconomic
factors as well as health service availability.19 As more
people are diagnosed with cancer in Australia and as treat-
ment costs increase,10 understanding the care-seeking beha-
vior of cancer patients is necessary to develop in-context
solutions for efficient policy-level change and service-level
interventions.16,20 Henceforth, local data is necessary to iden-
tify the predictors of health care utilization. The aim of this
study is to address this gap and answer the question: “what
are the demographic, health-related and socioeconomic
factors associated with health care utilization of Australian
cancer patients?”
Materials and methods
Data source and study sample
A total of 13,609 (aged 15 and over) participants from 7,230
households were interviewed as part of Wave 13 (year, 2013)
of the Household, Income and Labour Dynamics in Australia
(HILDA) annual survey.21 This nationally representative
longitudinal survey is conducted each year since 2001 by
the “Melbourne Institute of Applied Economic and Social
Research” and accessible via the “Australian Data
Archive”.22 Data are available for approved users from the
Department of Social Services, Government of Australia.
The survey was carried out in accordance with the ethical
guidelines approved by the University of Melbourne.23
Henceforth, additional ethical approvals were not required
for the current study.
Affected households were identified by a specific survey
question that asked whether anyone within a family was
diagnosed with any type of cancer. A total of 7,859 respon-
dents replied to the question and with the remainder being
missing values due to nonresponse to the question. Five
hundred and seventeen persons answered in the affirmative
and 7,342 persons responded negatively. Approximately
6.6% (517 out of 7,859) of HILDA participants in Wave
13 were diagnosed with cancer with the majority (90%) of
those currently undergoing cancer treatment.
Outcome variables
Health care utilization was measured using the following
variables:
● the number of doctor visits (family doctor or general
practitioner [GP from hereon]),
● the number of hospital admissions (overnight stay),
● the number of nights at the hospital (total nights’ stay
or hospital length of stay),
● hospital doctor visits (outpatient or casualty; yes or no),
● specialist doctor visits (excluding hospital outpatients
or casualty; yes or no),
● visits to a mental health professional (during the last
12 months; yes or no).
These individual-level data were collected from each parti-
cipant. In the regression model, the outcome variable,
namely, doctor visits, is denoted by a value of 1 if the patients
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visited doctors 10 times or more and 0 otherwise (0‒9 visits)
and for hospital admission, a value of 0 means no hospital
admissions and 1 otherwise (visited at least once).
Independent variables
Annual household disposable income (four quartiles) was
used as the primary predictor variable in the regression
analysis. Households in quartile 1 have incomes of $54,028
or less, quartile 2 between $54,029 to $85,929, quartile 3
between $85,930 to $124,425 and quartile 4 income was
more than $124,425. Several other variables were used as
explanatory variables. A dummy variable was generated for
education level (1= Education level ≤ high school, and 0
otherwise). The survey contained questions on body mass
index (BMI) level (<18.5=1, 18.5–24.9=2, 25–29.9=3,
≥30=4), level of psychological distress (depressed) level
(1= most times, 2= sometimes, 3= a little, 4= never),
Kessler psychological distress scale (K10) risk categories
(1= low, 2= moderate, 3= high, 4= very high), private health
insurance status and government health care card (yes=1 and
0 otherwise) and area of residence (urban,1 and 0 otherwise).
Urban and rural areas were defined based on the Australian
geographical classification,24 whereby urban means people
living in areas classified as major urban and other urban and
rural included localities outside the major urban centers.
Another dummy variable was used to assess whether the
respondents were born in Australia (=1) or otherwise (=0).
Other individual characteristics entered into the regression
analysis as control variables were gender (male, 1, female,0),
marital status (married, 1, 0 otherwise), age (1= age 19–44,
2= age 45–65, 3= age ≥65), smoking frequency (1= non-
smoker, 2= occasional, 3= regular), physical activity (1= less
than once, 2=1–3 times, 3= more than 3 times) per week and
self-assessed health (1= excellent, 2= very good, 3= good, 4=
fair, 5= poor). Financial distress was measured with the
respondent’s answer to the question “major worsening of
finances” (eg, went bankrupt) in the past twelve months
(1=yes and 0= no). Lastly, a dummy variable for the presence
of any long-term health condition (impairment or disability
to perform everyday activities) was created. A cross-tabula-
tion analysis indicated that this variable (dummy variable of
1= yes, and 0 otherwise) is highly correlated with health care
utilization of households. Explanatory variables selected for
inclusion were adapted from the literature.25–27
Statistical analysis
To determine the factors influencing health care use, this
paper applied an explanatory model building approach to
implement a multivariate binary logistic and a zero-inflated
Poisson regression. Initially, independent sample T-tests and
Pearson Chi-square tests were conducted to examine the
mean difference in health care utilization of cancer patients
based on their demographic and socioeconomic character-
istics. The types of tests employed varied based on the
characteristics of the response variable. In addition, the
Kruskal–Wallis H test (one-way ANOVA on ranks) was
used for independent variables with more than two inde-
pendent groups (income, age and psychological distress
level). For the principal outcome variables (number of
doctor visits and nights at the hospital), two-part regression
models were applied,26,28,29 which can account for a large
number of zero values.28 The first part of the analysis
included a binary logit regression model (multivariate) to
estimate the probability of health care use of participants
with cancer. Logistic regression is a well-recognized analy-
sis tool and is regularly used for binary response data in a
variety of applications including health care.30,31 In the
second part, the zero-inflated Poisson model (multivariate)
was used to account for count data that has a large number
of zero counts in key dependent variables. The possible
values of the variables, number of doctor visits and hospital
admissions include non-negative integers such as 0, 1, 2, 3
and so on. For this test, regression coefficients are estimated
with the maximum likelihood method. The detailed metho-
dology of the zero-inflated Poisson model is available in
several studies.32–34 Both of these regression equations
included several covariates. SPSS statistical software
(Version 23.0; IBM Corp, Armonk, NY) and Stata software
(Version 14.0) were used to perform all statistical analysis.
Results
Participant demographics
The descriptive analysis illustrates the demographic and
socioeconomic characteristics of the two groups. The sample
of respondents with cancer (N=517) were further divided
based on gender, country of birth, age, education level, area
of residence, level of psychological distress, self-assessed
health, doctor visits and health check-ups (Table 1).
Evidently as seen in Table 1, more than half (61.7%)
of people living with cancer in the HILDA data
(Wave 13) reside in major cities and greater than half
(51.6%) of cancer households were from the lowest
income quartile. Of the 517 respondents with cancer,
81.1% were born in Australia, 43.7% had an education
level beyond high school graduation, 43.3% were
Dovepress Rana et al
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female, 48.7% were aged over 65 and 58.4% of them
were covered by private health insurance. Moreover,
17.3% (high=10.8% and very high,6.5%) of cancer
patients reported a high level of psychological distress
and 39.5% (fair=26.7% and poor=12.8%) of them
viewed their current health status as fair or poor. On
average, 80.5% of people with a cancer diagnosis visited
specialists and 42.7% visited hospital doctors, in the
previous 12 months. Approximately, one in seven
(14.8%) of these cancer patients had pap smear test
and one in five (21.3%) had breast screening.
Comparatively, one in three male cancer patients had a
prostate (30.2%) and a bowel cancer (31.2%) screening
and 42.4% had an X-ray in the last 12 months.
Table 1 Demographic characteristics of Household, Income and Labour Dynamics in Australia survey participants (%)
Variables No cancer Cancer Variables No cancer Cancer
Remoteness area N=7342 N=517 Annual income* N=6713 N=517
Major city 59.8 61.7 Q1 Bottom quartile 38.9 51.6
Inner regional 26.5 24.8 Q2 Second quartile 22.8 15.9
Outer regional 12.2 12.0 Q3 Third quartile 19.3 15.1
Remote, very remote 1.3
0.2
1.4
0.2
Q4 Top quartile 19.0 17.4
Birth place* N=7342 N=512 Private health insurance cover N=7342 N=517
Born in Australia 77.4 81.1
Foreign born 22.6 18.9 Yes 53.1 58.4
Age N=7342 N=517 Marital status N=7342 N=517
19–44 33.8 11.0 Married 49.3 58.6
45–64 38.6 40.2 Residence area* N=6713 N=517
65 or more 27.6 48.7 Urban 83.9 85.1
Education N=7342 N=517 Gender* N=6713 N=517
≤ High school 50.9 56.3 Female 57.3 43.3
> High school 49.1 43.7 Self-assessed health* N=6497 N=460
PDS (psychological distress)* N=6494 N=461 Excellent 4.8 4.3
Very good 27.1 19.3
Low 56.1 63.3 Good 40.4 36.7
Moderate 21.8 19.3 Fair 22.3 26.7
High 13.4 10.8 Poor 5.4 12.8
Very high 8.7 6.5 BMI N=7340 N=517
Visited (last 12 months)* N=5765 N=483 <18.5 16.9 14.7
Psychiatrist 17.8 6.4 18.5–24.9 26.0 29.8
Specialist doctor 50.7 80.5 25–29.9 30.3 30.6
Hospital doctor 29.9 42.7 ≤30 26.8 25.0
Health checkups* N=6343 N=493 Visiting other health practitioners* N=5765 N=483
Pap smear 21.7 14.8
Breast screening 18.2 21.3 Podiatrist 19.4 22.8
Prostate check 13.8 30.2 Chiropractor 15.3 12.0
Bowel cancer 16.8 31.2 Physiotherapist 21.9 19.7
X-rays 28.1 42.4 Optometrist 44.2 45.8
Cholesterol test 58 63.5 Community nurse 6.3 8.9
Blood test 69 81.7 Other Allied health 9.1 7.2
Blood pressure 83.2 85.6 Provider
Notes: N= number of respondents who answered the corresponding question in Wave 13. *If the N of cancer and no cancer respondents are not equal to 7859 (number of
respondents who answered the question “Diagnosed with cancer”), there are missing values, either due to non-response or not asked. Q1 indicates bottom quartile, annual
income $54,028 or less; Q2 is second quartile, annual income $54,029 to $85,929; Q3 is third quartile, annual income 85,930 to $124,425 and Q4 is highest quartile, annual
income more than $124,425 (authors own calculation form the Wave 13 of HILDA data).
Rana et al Dovepress
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The mean differences in health care utilization of can-
cer patients by demographic and socioeconomic character-
istics had some interesting and surprising results (Table 2).
For several variables, the Kruskal–Wallis H test was con-
ducted which is more appropriate than the independent
sample T-test for the predictor variables with more than
two groups.31 Income was highly associated with the pat-
tern of health care utilization among individuals with
cancer. For instance, cancer patients in the lowest income
quartile made a higher number of GP visits (11.85 vs 6.62;
P<0.05) but stayed fewer nights in hospital (2.61 vs 2.99;
P<0.05) and had marginally smaller number hospital
admissions (0.68 vs 0.75; P<0.05) per year than the high-
est income group. Conversely, specialist doctors and men-
tal health doctor visits did not vary significantly among
cancer patients based on income quartile. On average,
female cancer patients have marginally more doctor visits,
0.36 times more hospital admissions (1.08 vs 0.72;
P<0.05) and 3.27 more nights’ stay in hospital (6.01 vs
2.74; P<0.05), all of which are considerably higher than
male cancer patients.
Being born outside of Australia (BOA) also appeared
to predict health care utilization among individuals with
cancer who reported a higher average of doctor visits
(14.51 vs 8.67; P<0.05), more hospital nights (4.68 vs
3.70; P<0.05) and marginally more specialist (89.1% vs
78.3%; P<0.05) and mental health doctor visits (10.9% vs
5.2%; P<0.05), than patients born in Australia. One prob-
able explanation of these findings is that 95% of the BOA
group reside in urban areas with the same population
reporting mixed education levels with just under half pos-
sessing qualifications more than high school study (data
not shown). The variations in the health care utilization
between the two groups were not statistically significant,
once other key explanatory variables were adjusted for in
the model.
The health care utilization of cancer patients aged 65 or
over was comparably higher than the two relatively
younger age groups: 19–44 years and 45–64 years.
Cancer patients aged 65 or more visited their GP through-
out the year more often (12.96 visits), compared to those
between the age of 45–64 years (7.33 visits) and 19–44
years (9.40 visits). For cancer patients (≥65 years), hospi-
tal length of stay was also higher with an average length of
stay (5.49 nights) compared to the 19–44 age bracket (2.90
nights) and those in the 45–64 years age bracket (2.56
nights). The mean differences are significant at a 95%
confidence interval (CI).
A higher level of education was found to significantly
predict access to and use of health care. For instance,
individuals with cancer who held a greater than high
school qualification had a higher number of doctor visits
(11.40 vs 8.61; P<0.05), hospital admissions (0.94 vs 0.82;
not significant at 95% CI), longer stays in hospital (4.79 vs
4.00; not significant at 95% CI) and higher number of
specialist doctor visits (83.3% vs 77.1%; P<0.05) than
cancer patients with education level of high school or less.
In Australia, individuals with private health insurance
(PHI) can opt to access universal health care (primary
health care and public hospitals) or use private providers
(private hospitals). Among cancer patients with PHI, spe-
cialist care visits are marginally higher (84.2% vs 75.4%;
P<0.05) than those without coverage. But GP visits (8.14
vs 12.30; P<0.05) and hospital admissions (0.73 vs 1.07;
P<0.05) are significantly higher among patients without
PHI cover than those with PHI, except for the average
number of hospital nights stay (4.17 vs 4.61; not signifi-
cant at 95% CI). As expected, cancer patients with other
long-term health conditions reported significantly higher
health care utilization of all kinds compared to those with-
out such conditions.
Individuals who reported high levels of psychological
distress were more likely to visit the GP more than 10
times (18.97 vs 6.93; P<0.05), higher length of stays in
hospital (8.90 vs 3.02; P<0.05) and significantly more
visits to mental health professionals (21.4% vs 2.6%;
P<0.05) than those with lower distress levels. Urban can-
cer patients reported a greater number of visits to GPs
(10.51 vs 9.14; P<0.05), longer hospital stays (4.08 vs
3.59; P<0.05), higher percentage of mental health doctor
visits (7.4% vs 1.3%; P<0.05) but slightly lower hospital
admissions (0.83 vs 0.96; P<0.05) compared to those in
rural areas.
State-based differences were also observed (although
statistically not significant) in patterns of health care utili-
zation of cancer patients. For instance, Victorian patients
had the highest number of hospital admissions and hospital
nights’ stay compared to those living in other states, with
South Australia and Western Australia the lowest, respec-
tively. Average specialist doctor visits are highest in South
Australia with Western Australia the lowest. However,
there was no association between a lower number of
specialist doctor visits in Western Australia and fewer
overall hospital admissions in the state. Further analysis
revealed that 20% of cancer patients from Western
Australia had hospital stays of 10 nights or more which
Dovepress Rana et al
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reflects its lower population density and longer distances
involved in accessing treatment (data not shown).
Of the 517 cancer patients, 5% (n=25) had a major
worsening of finances with 11 of them from the lowest
income quartile, although this finding was not significant
at a 5% confidence interval (data not shown). Financial
distress was not related to the place of residence (ie urban
vs rural), household income or gender. However, having
major financial distress is associated with fewer nights’
stay in hospital (4.36 vs 2.48; P=0.04) compared to no
financial distress and a significantly higher number of
visits to a mental health professional (21.7% vs 5.4%;
P<0.05).
The key determinants of health care utilization of cancer
patients by socioeconomic and demographic characteristics
are shown in Table 3. The adjusted logistic regression
results indicate that younger individuals with cancer (age
<44) were 2.74 times more likely to have 10 or more doctor
visits than older patients (≥65) per year (odds ratio 2.74;
P<0.05). Further analyses of income status and the type and
frequency of cancer care accessed showed that cancer
patients from the lowest income quartile have a lower
probability of hospital admission (odds ratio 0.702;
P<0.05) compared to patients from the highest income
quartile. In addition, women patients have 1.65 times higher
probability of hospital admissions (odds ratio 1.65; P<0.05).
The results also show that cancer patients with PHI are
twice more likely to access a GP (ten times or more)
compared to patients without private cover (odds ratio
2.04; P<0.05). However, the heterogeneity in hospital
admissions was not statistically significant (odds ratio
0.86; P>0.05).
Access and uptake of specialist care predicted subse-
quent health care utilization among individuals living with
cancer. Cancer patients who visited hospital doctors (2.3
times) or accessed specialist doctors (2.7 times) were less
likely to access GP care (10 or more times) and, impor-
tantly, less likely to be subsequently admitted to hospital
(odds ratio 0.432 and 0.360, respectively; P<0.05). Cancer
patients who received care from a hospital doctor were
seven times less likely to be admitted to hospital while
those receiving specialist care had a 1.87 times lower
chance of hospital admission (odds ratio 0.141 and
0.535, respectively; P<0.05).
Further analysis on factors impacting health care utili-
zation of cancer patients using the zero-inflated Poisson
regression model shows several key and interesting find-
ings (Table 4). For instance, self-assessed health, gender,
long-term health condition and visits to hospital and spe-
cialist doctors significantly influence the number of doctor
visits and hospital admissions of cancer patients. A unit
increase in self-assessed health increases the expected
number of doctor visits by a factor of 1.264 (exponent of
0.234) and hospital admissions by 1.328 (exponent of
0.284). In addition, for a male cancer patient, the expected
number of zero doctor visit is 0.908 (exponent of −0.096)
times and expected number of zero hospital admissions is
0.69 (exponent of −0.371) times the expected number of
females, while holding all other variables constant. This
indicates that female cancer patients have a higher like-
lihood than males of non-zero counts for number of doctor
visits and hospital admissions. Furthermore, cancer
patients with other long-term health conditions have
1.495 (exponent of 0.402) times, and those without a
specialist doctor visit have 2.567 (exponent of 0.943)
times the expected number of hospital admissions than
patients with no long-term health conditions and specialist
doctor visits, respectively.
Finally, while predicting the “Certain Zero” group, the
findings of the zero-inflated regression show that if a
cancer patient has no long-term health conditions, the
odds that s/he would be in the “Certain Zero” group
(zero or no doctor visits) is higher (results not shown).
On the other hand, patients who visited hospital doctors
have a higher likelihood of being in the “Certain Zero”
group of no hospital admissions (results not shown).
The level of psychological distress among cancer
patients varied significantly based on their demographic
characteristics and health care utilization (Table 5). Cancer
patients with lower education levels, aged less than 45
years, female or were not currently married reported a
higher level of psychological distress compared to those
who were highly educated, aged 45 and over, male and
married.
Education level also appears to predict psychological
distress as cancer patients with a qualification level of
secondary school or lower reported very high levels of
psychological distress compared to those with higher edu-
cation status (9.9% vs 4.1%; P=0.019). About 6.4% of
urban cancer patients reported very high psychological
distress compared to 7.4% of rural cancer patients
(P=0.53). Cancer patients with very high psychological
distress level had a significantly higher number of hospital
doctor visits (42.9% vs 35.1%; P<0.05), admissions
(36.6% vs 15.2%; P=0.043) and more than one night
stay (46.4% vs 24.1%; P<0.05) than those reporting a
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lower level of distress. Noticeably, only one in five
(21.4%) cancer patients with very high psychological dis-
tress has visited a mental health professional.
Discussion
The findings demonstrate trends and inequalities in health
care utilization across the cancer continuum associated
with advancing age, gender, income, education status,
rurality, urbanity, migrant status, private health insurance
coverage and access to specialist care. Given that even
moderate health care utilization has been associated with
longer survival times,35,36 inequalities that act as barriers
to receiving care may have devastating implications for
those individuals with cancer.
In society, increased health care utilization is asso-
ciated with advancing age in Australia, with hospitaliza-
tion rates for those 65 years and over four times higher
than the rest of the population. This older age group also
accesses GP care (10 visits or more times per year) at
double the rate of those under 65.37,38 The study results
show that younger adults (19–45 years) with cancer appear
to contradict previously reported Australian trends by
accessing their GP at a higher rate than older age groups
with cancer. Reasons for such health care‒-seeking beha-
vior are unclear39; however, younger adults’ apparent pre-
ferences for GP-led care may present a more effective and
lower cost means of disseminating cancer survivorship
interventions among this age-group.
The findings of gender-based utilization of health care
largely reflect current trends in Australian health care. It
was reported in 2017 that women seek hospital care more
frequently, stay in the hospital longer and access all types
of health care more than men.40 This was confirmed for
men with poorer health who are still less likely to access
all types of health care as reported in the “Ten to Men
Australian Longitudinal Study on Male Health”.41
However, the study results show that men with cancer
are more likely to seek out specialist care than females
with cancer, possibly reflecting a masculine tendency to
seek out a viewpoint on their illness which they perceive
to be dominant or authoritative.42 Masculine inclinations
to access specialist care may also explain an increased
uptake of screening compared to those without a cancer
diagnosis as increased usage of diagnostic tests are asso-
ciated with specialist care.43
Despite Australia becoming the wealthiest country in
the world in 2018 based on median wealth per adult,44
there is clear evidence that income inequality is associated
with differing patterns of health care utilization. For those
of low income, less engagement with hospital-based care
and increased use of GP services may reflect the financial
pressures of remaining in paid work to support the high
cost of living in Australia.44 However, these patterns were
reversed in high-income individuals who not only
accessed hospital care more but accessed specialist care
and sought treatment from mental health professionals
more often than lower income cancer patients.
Noticeably, cancer patients reporting financial distress
had the lowest length of stay of all, with single people
most affected. Given financial distress has been linked
with decision-making on treatment,45 reduced length of
stay in this sample may reflect a need to leave the hospital
early to avoid the loss of income and the cost of treatment.
The usual factors such as advanced education status
and urban residence linked with increased health care
utilization were also found in this study; however, both
variables were also correlated with an increased probabil-
ity of psychological distress. However, increased length of
hospital stay for rural individuals is typical in the geogra-
phically dispersed Australian context and reflects the lack
of appropriate local treatment services for rural people and
increases their need to travel for medical treatment.40,43
The findings of higher psychological distress in more
educated, urban-dwelling individuals with cancer contrast
with other studies where rural individuals of lower education
status report higher psychological distress.46,47 Accessing
mental health services48 and positive attitudes49 toward seek-
ing psychological support have previously been associated
with higher incomes, although it is unclear how higher
income increases care-seeking behaviors in this study popu-
lation. Lastly, cancer patients with very high levels of psy-
chological distress showed a higher level of health care
utilization; however, around four in five of these patients
surprisingly did not seek mental health care services.
Significantly increased health care utilization by migrants
with cancer is a new finding in the Australian context; how-
ever, this finding may in part further explain more favorable
cancer mortality outcomes among Australian migrants as
previously reported in a 2012 study.17 More broadly, it was
found that state-based patterns of cancer care differ widely
and are not explainable by typical patterns of health-seeking
behavior. Nevertheless, significant variation in cancer care
may reflect ongoing state-based differentials in the (in)effi-
ciency of care delivery50 as well as a lack of care coordina-
tion reported in aspects of cancer services.51 How to achieve
consistency in care delivery is a federal health priority in
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Australia, with further research needed on improving the
coordination and efficiency of care at multiple levels.
Importantly for care coordination, specialist care appears to
be strongly linked with the prevention of hospitalization
which highlights both the value of specialists in the health
care system and their contribution to improved care
coordination.
While cross-sectional analysis is susceptible to the risk
of bias, the representative population data used in this
study provides a solid basis for the results obtained and
enables further exploration of the demographic and socio-
cultural drivers of health care utilization in cancer patients
in Australia. The results also serve to inform which popu-
lations are experiencing inequality and identifies potential
areas where tailored solutions might inform models for
improving service access and care optimization.
Limitations
This study has some limitations. Data inadequacy, for
instance, means a lack of follow-up questions like what
type of cancer and time diagnosed with cancer could not
be factored into or controlled for in the regression analysis.
Due to the cross-sectional nature of the data, the causality
effect between variables could not be estimated. Future
studies using longitudinal data may be able to use more in-
depth confounding estimates of the causal relationship.
The fewer number of respondents with cancer (in the
database) also limited the ability to create more age
groups. Lastly, the expenditure on and utilization of health
care are subject to several unobserved variables which
may lead to omitted variable bias.52 Although this study
has attempted to limit the bias through the inclusion of
relevant covariates and by using a two-part model, some
potential bias may still exist.27,51 Lastly, the term “no
cancer” means survey respondents reported negative to
the question “have you been diagnosed with any type of
cancer?” However, this does not mean these respondents
do not have other long-term health conditions. Therefore,
the heterogeneity of health expenditure and health care
utilization between the two groups (cancer vs no cancer)
should be interpreted with caution. Future studies may use
“quasi-experimental design” or “social experiments” to
address these methodological issues.
Conclusions
The findings from this study have implications for policy-
makers and health professionals as they reflect structural
inequalities in Australian society which impact upon
cancer patients, their treatment pathways and ultimately
their survival or otherwise. Factors such as age, gender,
income, psychological health, education and place of resi-
dence indicate the need for appropriate policy and program
responses. Encouragingly, the findings also point to the
value of some models of care in specific cohorts as well as
the value of specialists in preventing hospitalizations
through improved care coordination. Further research
into effective models of care is needed to understand
why, where and when they work and how their effective-
ness can be implemented across the health system.
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Supplementary material
Results from the GLM regression model
The GLM approach was used to examine the key factors
influencing healthcare utilization (Table S1).
Two outcome variables have been used to measure
healthcare utilization: the log of the number of doctor
visits (LnDrV) and a log of the number of nights stay in
the hospital (LnHsN). For cancer patients, a one unit
increase in BMI leads to a growth in number of doctor
visits by 0.8% and for non-cancer patients, it increases
by 0.5% and the results are significant. Cancer patients
with other long-term health conditions have on average
24.7% more doctor visits compared to cancer patients
with no long-term health conditions. A cancer patient
with higher psychological distress has 7.8% more doctor
visits compared to those without the condition. Again,
having private health insurance increases the doctor
visits by 9.1% for cancer patients and 10.6% for non-
cancer patients. The factors that significantly influence
the number of nights stay at the hospital are other long-
term health conditions, BMI and level of psychological
distress. However, for non-cancer patients having pri-
vate health insurance increases the nights’ stay at the
hospital by 10.6%. Lastly, for non-cancer patients higher
visits to specialist doctors reduces nights stay in the
hospital by 14.5%.
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Table S1 Factors influencing healthcare utilization of cancer patients (generalised linear model)
LnDrV LnHsN
Cancer No Cancer Cancer No Cancer
LnDY −0.002 (0.02) −0.109*(0.01) −0.000 (0.05) −0.114*(0.02)
Age −0.000 (0.00) 0.000 (0.00) 0.000 (0.001) 0.000 (0.001)
Gender −0.006 (0.04) −0.058*(0.01) −0.025 (0.16) −0.060*(0.001)
Edu1 0.071 (0.05) 0.013 (0.01) 0.080*(0.18) 0.014 (0.06)
BMI 0.008*(0.00) 0.005*(0.00) 0.007*(0.01) 0.005*(0.000)
MaritalStatus −0.039 (0.04) 0.009 (0.01) −0.026 (0.17) 0.008 (0.05)
Urb Dummy −0.059 (0.05) −0.018 (0.01) −0.066 (0.17) −0.018 (0.051)
HIn Dummy 0.091*(0.05) 0.106*(0.01) 0.077 (0.18) 0.106*(0.06)
Int Access 0.079 (0.05) 0.015 (0.01) 0.089 (0.19) 0.020 (0.01)
Lng Health −0.274*(0.04) −0.150*(0.01) −0.311*(0.20) −0.155*(0.06)
PshyCo 0.078*(0.02) 0.078*(0.006) 0.087*(0.11) 0.080*(0.006)
DrV
SDr −0.079 (0.04) −0.145* (0.01)
HNght 0.009*(0.00) 0.004*(0.002)
Intercept −0.509*(0.33) 0.084*(0.11) −0.468 (0.32) 0.121 (0.11)
Dev/df 0.351 0.581 0.159 0.159
Adj R-Sq 0.595 0.420 0.709 0.515
Note: *P<0.05. Standard error in the parenthesis.
Abbreviations: LnDY, log of annual household total disposable income; Gender, (male,1 and female,0); Edu1, Education level dummy; BMI, Body mass index; Hld size,
Household size; Urb Dummy, Urban resident dummy; Hln Dummy, Health insurance dummy; Int Access, Internet access at home; Lng Health, Long term health conditions;
PshyCo, risk category score of Kessler Psychological Distress scale; DrV, Number of doctor visits of participants; SDr, Seen a specialist doctor in the last 12 months; HNght,
Number of nights at hospital participants. Dev/df= Deviance divided by the degrees of freedom and this is used to measure the goodness of fit.
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